{"product_id":"mi-260","title":"Macrophage Inflammatory Protein-2 (MIP-2), Mouse Recombinant","description":"\u003cp\u003eMouse recombinant MIP-2 is produced in genetically engineered yeast, and purified by sequential chromatography.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular weight:\u003c\/strong\u003e 7.8 kDa\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e Over 95% pure by SDS gel electrophoresis, with low level of endotoxin.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -80°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e Several months at -80°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiological activity:\u003c\/strong\u003e The biological activity of recombinant murine MIP-2 is determined by a localized inflammatory response when injected into the footpads of mice (Wolpe, S.D. et al, Exp. Med. 167, 570 (1987)).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e 0.05 M Ammonium Acetate. Concentration: 1.0 mg protein\/ml.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReferences:\u003cbr\u003e\u003cbr\u003e\u003c\/strong\u003e1. Nathan, C.F. (1987)J. Clin. Invest. 79:319\u003cbr\u003e2. Wolpe S.D. et al. (1989) Proc. Natl. Acad. Sci. (USA) 86:612\u003cbr\u003e3. Tekamp-Olson. P. et al. (1990) J. Exp. Med. 172:911\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c!-- AB_PUBLISHED_USE_START --\u003e\n\u003csection class=\"ab-published-use\"\u003e\n\u003ch3 id=\"ab-published-use-mi-260\"\u003ePublished product use\u003c\/h3\u003e\n\u003cp\u003eA peer-reviewed study reported use of murine MIP-2 purchased from Austral Biologicals:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eExperimental chemokine reagent:\u003c\/strong\u003e Murine MIP-2 from Austral Biologicals was used as a reagent in a study of chemokine regulation during collagen-induced arthritis. \u003ca href=\"https:\/\/doi.org\/10.1172\/jci117993\" rel=\"noopener\" target=\"_blank\"\u003eKasama et al., Journal of Clinical Investigation (1995)\u003c\/a\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/section\u003e\n\u003c!-- AB_PUBLISHED_USE_END --\u003e\n\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_MI-260_Datasheet.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"10 µg","offer_id":52518881755438,"sku":"MI-260-3","price":200.0,"currency_code":"USD","in_stock":true},{"title":"50 µg","offer_id":52518881788206,"sku":"MI-260-4","price":800.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-mi-260-10ug.png?v=1788008309","url":"https:\/\/www.australbiologicals.com\/products\/mi-260","provider":"Austral Biologicals","version":"1.0","type":"link"}